Professor Nadir Arber, who has led research into a new drug used to treat coronavirus patients, at Ichilov Medical Centre, Tel Aviv. Rosie Scammell for The National
Professor Nadir Arber, who has led research into a new drug used to treat coronavirus patients, at Ichilov Medical Centre, Tel Aviv. Rosie Scammell for The National
Professor Nadir Arber, who has led research into a new drug used to treat coronavirus patients, at Ichilov Medical Centre, Tel Aviv. Rosie Scammell for The National
Professor Nadir Arber, who has led research into a new drug used to treat coronavirus patients, at Ichilov Medical Centre, Tel Aviv. Rosie Scammell for The National

Israeli drug holds promise of stopping fatal Covid-19 immune response


Rosie Scammell
  • English
  • Arabic

After successfully treating 30 patients with severe cases of Covid-19, Israeli scientists in Tel Aviv are hopeful their new drug can play a key role in saving lives and helping the world recover from the coronavirus pandemic.

“It’s difficult to see a patient with Covid-19 because they cannot breathe, it’s like drowning,” said Nadir Arber, who has led the study at Tel Aviv’s Ichilov Medical Centre.

“Now they can start to breathe again,” he said.

The drug developed by the team at Ichilov hospital prevents an overreaction of the immune system, which Dr Arber said affects 6 to 7 per cent of coronavirus patients.

“What we call the cytokine storm. Our immune system thinks there’s a big invasion, they’re shooting everywhere,” he said of the syndrome, which can be fatal.

Dr Shiran Shapira, who runs the laboratory where the drug was developed, holds an empty vial which contained the new medicine. Rosie Scammell for The National
Dr Shiran Shapira, who runs the laboratory where the drug was developed, holds an empty vial which contained the new medicine. Rosie Scammell for The National

Ichilov released its initial findings earlier this month, from a stage one trial of 30 patients aged between 37 and 78. All but one recovered quickly and they were discharged after four days, on average, Dr Arber said, shorter than the six-day period for coronavirus patients across Israel.

The treatment was stopped for one patient who was admitted to the intensive care unit, but she ultimately recovered.

“So this is it and now there is a huge demand from all over the world; I’m speaking to prime ministers, presidents, and this is very exciting,” said Dr Arber, who heads the hospital’s Integrated Cancer Prevention Centre.

The new drug harnesses a gene, known as CD24, that suppresses the immune system. Dr Arber has worked on the gene for 20 years.

Researchers placed CD24 on to exosomes – extremely small molecules derived from cell membranes – to develop a drug that patients can inhale.

“It goes directly to the lung. It’s sophisticated but it’s easy,” Dr Arber said.

Dr Shiran Shapira, who runs the laboratory where the drug was developed, stands beside a microscope image of cells which were used to create the new treatment. Rosie Scammell for The National
Dr Shiran Shapira, who runs the laboratory where the drug was developed, stands beside a microscope image of cells which were used to create the new treatment. Rosie Scammell for The National

While the initial results are promising and patients suffered no side effects, the research is in its infancy.

Phase two trials will expand the study to a few dozen patients and include a control group, while the third phase that may begin later this year will involve hundreds or potentially thousands of patients.

These broader studies will include patients internationally, although Dr Arber did not say which countries might be involved.

  • Medical personnel work inside the coronavirus intensive care unit at Sheba Medical Center, close to Tel Aviv. Rosie Scammell / The National
    Medical personnel work inside the coronavirus intensive care unit at Sheba Medical Center, close to Tel Aviv. Rosie Scammell / The National
  • Medical personnel are seen on a screen in the observation room of the coronavirus intensive care unit at Sheba Medical Center. Rosie Scammell / The National
    Medical personnel are seen on a screen in the observation room of the coronavirus intensive care unit at Sheba Medical Center. Rosie Scammell / The National
  • Medical personnel work inside the coronavirus intensive care unit at Sheba Medical Center, close to Tel Aviv. Rosie Scammell / The National
    Medical personnel work inside the coronavirus intensive care unit at Sheba Medical Center, close to Tel Aviv. Rosie Scammell / The National
  • The Sheba Medical Centre coronavirus intensive care unit. In addition to this ward, there are numerous specialised coronavirus units at Sheba Medical Centre. They including one for children and another for psychiatric patients. Rosie Scammell for The National.
    The Sheba Medical Centre coronavirus intensive care unit. In addition to this ward, there are numerous specialised coronavirus units at Sheba Medical Centre. They including one for children and another for psychiatric patients. Rosie Scammell for The National.

Greece has offered to participate in future trials of the “miracle drug”, Israeli Prime Minister Benjamin Netanyahu said Monday after separate meetings with his Greek counterpart, Kyriakos Mitsotakis, and Dr Arber.

Shiran Shapira, a doctor who runs the laboratory where the drug was developed, said she was feeling positive about the treatment’s potential.

“It’s really fast and easy to produce, and even cheap,” she said. “We were working on CD24 for two decades and with the exosomes for almost five years, so we had all the parts, and we just combined them and developed this technology.

Dr Shiran Shapira, who runs the laboratory where the drug was developed, points to a screen showing exosomes, extremely small molecules derived from cell membranes, which were used to develop the new treatment. Rosie Scammell for The National
Dr Shiran Shapira, who runs the laboratory where the drug was developed, points to a screen showing exosomes, extremely small molecules derived from cell membranes, which were used to develop the new treatment. Rosie Scammell for The National

As scientists develop new ways to treat Covid-19 and its effects, doctors have turned to existing drugs to help patients.

A UK study published in June found that dexamethasone, an anti-inflammatory steroid, cut the risk of death by more than a third among patients on ventilators.

Randy Cron, who in 2019 co-edited a book on the cytokine storm syndrome, said he predicted at the start of the pandemic that “immunosuppressive steroids are probably going to save the day”.

“Steroids aren’t a home run either, they saved maybe a third of the patients’ lives that got them, but that’s better than nothing,” he said.

The sense of urgency to tackle the pandemic and prevent patients’ immune systems going into overdrive has had one “silver lining” for Dr Cron – that people are learning about cytokine storm syndrome.

“If you don’t recognise a cytokine storm, you’re not going to treat it. And if you don’t treat it, patients are going to die,” said Dr Cron, a professor of paediatrics at the University of Alabama at Birmingham.

Aware of the grave risks of such a scenario, Bibi Ayesha, a doctor in New York, led a task force last year to identify patients at risk of developing the syndrome.

The vast majority of 288 patients included in the study were treated with steroids, while 31 were given biological treatment commonly known as antibodies.

“Biological therapy has a very narrow window,” said Dr Ayesha, a rheumatologist at Montefiore Medical Centre in New York. “If it’s [administered] early, it is proven to be beneficial.”

“There is no perfect cure, it’s the timing,” she said. She cautioned that to understand the most effective treatments, more data are needed.

“There has to be a combined effort where all these specialists can put their minds together and help the patient in a timely manner,” including rheumatologists and immunologists, she said.

Despite inoculation drives getting under way in the US, Israel and elsewhere, Dr Arber said the new drug will play an essential role in overcoming the pandemic.

“This, with vaccinations … we can go back to normal life,” he said. “We must go back to normal life.”

  • A man receives a dose of a vaccine against Covid-19 at St Paul’s Church in Abu Dhabi. Khushnum Bhandari / The National
    A man receives a dose of a vaccine against Covid-19 at St Paul’s Church in Abu Dhabi. Khushnum Bhandari / The National
  • Pupils faced foggy conditions on their first day back at Gems United Indian School in Abu Dhabi. Victor Besa / The National
    Pupils faced foggy conditions on their first day back at Gems United Indian School in Abu Dhabi. Victor Besa / The National
  • Elvin Toro, 26, a former army medic, organises his syringes before giving out the next dose of the Covid-19 vaccine to a local resident at Central Falls High School in Central Falls, Rhode Island, USA. AFP
    Elvin Toro, 26, a former army medic, organises his syringes before giving out the next dose of the Covid-19 vaccine to a local resident at Central Falls High School in Central Falls, Rhode Island, USA. AFP
  • A health worker administers a Covid-19 vaccine to a municipal worker at a private hospital in New Delhi, India. AP Photo
    A health worker administers a Covid-19 vaccine to a municipal worker at a private hospital in New Delhi, India. AP Photo
  • A firefighter gives disinfectant gel to women out shopping in Mexico City. AP Photo
    A firefighter gives disinfectant gel to women out shopping in Mexico City. AP Photo
  • Britain's Prime Minister Boris Johnson visits the QuantuMDx Biotechnology company, which has developed a 30-minute PCR diagnostics device, in Newcastle, Britain. Reuters
    Britain's Prime Minister Boris Johnson visits the QuantuMDx Biotechnology company, which has developed a 30-minute PCR diagnostics device, in Newcastle, Britain. Reuters
  • Packaging and fridges used to store Covid-19 vaccine are seen at a DHL facility in Sydney, Australia. EPA
    Packaging and fridges used to store Covid-19 vaccine are seen at a DHL facility in Sydney, Australia. EPA
  • People wait in their vehicles to receive doses of Covid-19 vaccine at a drive-thru 'vaccination super station' operated by UC San Diego Health in downtown San Diego, California, USA. Reuters
    People wait in their vehicles to receive doses of Covid-19 vaccine at a drive-thru 'vaccination super station' operated by UC San Diego Health in downtown San Diego, California, USA. Reuters
  • A girl slides at a playground in Barcelona, Spain. AP Photo
    A girl slides at a playground in Barcelona, Spain. AP Photo
  • A fruit vendor walks in front of a mural in Port-au-Prince, Haiti. EPA
    A fruit vendor walks in front of a mural in Port-au-Prince, Haiti. EPA
  • A vendor makes a flower bouquet at a market in Manila. AFP
    A vendor makes a flower bouquet at a market in Manila. AFP
  • A couple sits at a 'Private Snow Globe' as they celebrate Valentine's day at Magical pub The Cauldron in New York. AFP
    A couple sits at a 'Private Snow Globe' as they celebrate Valentine's day at Magical pub The Cauldron in New York. AFP
The five pillars of Islam

1. Fasting

2. Prayer

3. Hajj

4. Shahada

5. Zakat 

How to help

Send “thenational” to the following numbers or call the hotline on: 0502955999
2289 – Dh10
2252 – Dh 50
6025 – Dh20
6027 – Dh 100
6026 – Dh 200

Trump v Khan

2016: Feud begins after Khan criticised Trump’s proposed Muslim travel ban to US

2017: Trump criticises Khan’s ‘no reason to be alarmed’ response to London Bridge terror attacks

2019: Trump calls Khan a “stone cold loser” before first state visit

2019: Trump tweets about “Khan’s Londonistan”, calling him “a national disgrace”

2022:  Khan’s office attributes rise in Islamophobic abuse against the major to hostility stoked during Trump’s presidency

July 2025 During a golfing trip to Scotland, Trump calls Khan “a nasty person”

Sept 2025 Trump blames Khan for London’s “stabbings and the dirt and the filth”.

Dec 2025 Trump suggests migrants got Khan elected, calls him a “horrible, vicious, disgusting mayor”

Fines for littering

In Dubai:

Dh200 for littering or spitting in the Dubai Metro

Dh500 for throwing cigarette butts or chewing gum on the floor, or littering from a vehicle. 
Dh1,000 for littering on a beach, spitting in public places, throwing a cigarette butt from a vehicle

In Sharjah and other emirates
Dh500 for littering - including cigarette butts and chewing gum - in public places and beaches in Sharjah
Dh2,000 for littering in Sharjah deserts
Dh500 for littering from a vehicle in Ras Al Khaimah
Dh1,000 for littering from a car in Abu Dhabi
Dh1,000 to Dh100,000 for dumping waste in residential or public areas in Al Ain
Dh10,000 for littering at Ajman's beaches 

F1 The Movie

Starring: Brad Pitt, Damson Idris, Kerry Condon, Javier Bardem

Director: Joseph Kosinski

Rating: 4/5

The%20specs%3A%202024%20Mercedes%20E200
%3Cp%3E%3Cstrong%3EEngine%3A%20%3C%2Fstrong%3E2.0-litre%20four-cyl%20turbo%20%2B%20mild%20hybrid%0D%3Cbr%3E%3Cstrong%3EPower%3A%20%3C%2Fstrong%3E204hp%20at%205%2C800rpm%20%2B23hp%20hybrid%20boost%0D%3Cbr%3E%3Cstrong%3ETorque%3A%20%3C%2Fstrong%3E320Nm%20at%201%2C800rpm%20%2B205Nm%20hybrid%20boost%0D%3Cbr%3E%3Cstrong%3ETransmission%3A%20%3C%2Fstrong%3E9-speed%20auto%0D%3Cbr%3E%3Cstrong%3EFuel%20consumption%3A%20%3C%2Fstrong%3E7.3L%2F100km%0D%3Cbr%3E%3Cstrong%3EOn%20sale%3A%20%3C%2Fstrong%3ENovember%2FDecember%0D%3Cbr%3E%3Cstrong%3EPrice%3A%20%3C%2Fstrong%3EFrom%20Dh205%2C000%20(estimate)%3C%2Fp%3E%0A
Match info

Uefa Nations League Group B:

England v Spain, Saturday, 11.45pm (UAE)

Expo details

Expo 2020 Dubai will be the first World Expo to be held in the Middle East, Africa and South Asia

The world fair will run for six months from October 20, 2020 to April 10, 2021.

It is expected to attract 25 million visits

Some 70 per cent visitors are projected to come from outside the UAE, the largest proportion of international visitors in the 167-year history of World Expos.

More than 30,000 volunteers are required for Expo 2020

The site covers a total of 4.38 sqkm, including a 2 sqkm gated area

It is located adjacent to Al Maktoum International Airport in Dubai South

Francesco Totti's bio

Born September 27, 1976

Position Attacking midifelder

Clubs played for (1) - Roma

Total seasons 24

First season 1992/93

Last season 2016/17

Appearances 786

Goals 307

Titles (5) - Serie A 1; Italian Cup 2; Italian Supercup 2

How to get there

Emirates (www.emirates.com) flies directly to Hanoi, Vietnam, with fares starting from around Dh2,725 return, while Etihad (www.etihad.com) fares cost about Dh2,213 return with a stop. Chuong is 25 kilometres south of Hanoi.
 

Various Artists 
Habibi Funk: An Eclectic Selection Of Music From The Arab World (Habibi Funk)
​​​​​​​

VEZEETA PROFILE

Date started: 2012

Founder: Amir Barsoum

Based: Dubai, UAE

Sector: HealthTech / MedTech

Size: 300 employees

Funding: $22.6 million (as of September 2018)

Investors: Technology Development Fund, Silicon Badia, Beco Capital, Vostok New Ventures, Endeavour Catalyst, Crescent Enterprises’ CE-Ventures, Saudi Technology Ventures and IFC

Mercer, the investment consulting arm of US services company Marsh & McLennan, expects its wealth division to at least double its assets under management (AUM) in the Middle East as wealth in the region continues to grow despite economic headwinds, a company official said.

Mercer Wealth, which globally has $160 billion in AUM, plans to boost its AUM in the region to $2-$3bn in the next 2-3 years from the present $1bn, said Yasir AbuShaban, a Dubai-based principal with Mercer Wealth.

Within the next two to three years, we are looking at reaching $2 to $3 billion as a conservative estimate and we do see an opportunity to do so,” said Mr AbuShaban.

Mercer does not directly make investments, but allocates clients’ money they have discretion to, to professional asset managers. They also provide advice to clients.

“We have buying power. We can negotiate on their (client’s) behalf with asset managers to provide them lower fees than they otherwise would have to get on their own,” he added.

Mercer Wealth’s clients include sovereign wealth funds, family offices, and insurance companies among others.

From its office in Dubai, Mercer also looks after Africa, India and Turkey, where they also see opportunity for growth.

Wealth creation in Middle East and Africa (MEA) grew 8.5 per cent to $8.1 trillion last year from $7.5tn in 2015, higher than last year’s global average of 6 per cent and the second-highest growth in a region after Asia-Pacific which grew 9.9 per cent, according to consultancy Boston Consulting Group (BCG). In the region, where wealth grew just 1.9 per cent in 2015 compared with 2014, a pickup in oil prices has helped in wealth generation.

BCG is forecasting MEA wealth will rise to $12tn by 2021, growing at an annual average of 8 per cent.

Drivers of wealth generation in the region will be split evenly between new wealth creation and growth of performance of existing assets, according to BCG.

Another general trend in the region is clients’ looking for a comprehensive approach to investing, according to Mr AbuShaban.

“Institutional investors or some of the families are seeing a slowdown in the available capital they have to invest and in that sense they are looking at optimizing the way they manage their portfolios and making sure they are not investing haphazardly and different parts of their investment are working together,” said Mr AbuShaban.

Some clients also have a higher appetite for risk, given the low interest-rate environment that does not provide enough yield for some institutional investors. These clients are keen to invest in illiquid assets, such as private equity and infrastructure.

“What we have seen is a desire for higher returns in what has been a low-return environment specifically in various fixed income or bonds,” he said.

“In this environment, we have seen a de facto increase in the risk that clients are taking in things like illiquid investments, private equity investments, infrastructure and private debt, those kind of investments were higher illiquidity results in incrementally higher returns.”

The Abu Dhabi Investment Authority, one of the largest sovereign wealth funds, said in its 2016 report that has gradually increased its exposure in direct private equity and private credit transactions, mainly in Asian markets and especially in China and India. The authority’s private equity department focused on structured equities owing to “their defensive characteristics.”

Ten tax points to be aware of in 2026

1. Domestic VAT refund amendments: request your refund within five years

If a business does not apply for the refund on time, they lose their credit.

2. E-invoicing in the UAE

Businesses should continue preparing for the implementation of e-invoicing in the UAE, with 2026 a preparation and transition period ahead of phased mandatory adoption. 

3. More tax audits

Tax authorities are increasingly using data already available across multiple filings to identify audit risks. 

4. More beneficial VAT and excise tax penalty regime

Tax disputes are expected to become more frequent and more structured, with clearer administrative objection and appeal processes. The UAE has adopted a new penalty regime for VAT and excise disputes, which now mirrors the penalty regime for corporate tax.

5. Greater emphasis on statutory audit

There is a greater need for the accuracy of financial statements. The International Financial Reporting Standards standards need to be strictly adhered to and, as a result, the quality of the audits will need to increase.

6. Further transfer pricing enforcement

Transfer pricing enforcement, which refers to the practice of establishing prices for internal transactions between related entities, is expected to broaden in scope. The UAE will shortly open the possibility to negotiate advance pricing agreements, or essentially rulings for transfer pricing purposes. 

7. Limited time periods for audits

Recent amendments also introduce a default five-year limitation period for tax audits and assessments, subject to specific statutory exceptions. While the standard audit and assessment period is five years, this may be extended to up to 15 years in cases involving fraud or tax evasion. 

8. Pillar 2 implementation 

Many multinational groups will begin to feel the practical effect of the Domestic Minimum Top-Up Tax (DMTT), the UAE's implementation of the OECD’s global minimum tax under Pillar 2. While the rules apply for financial years starting on or after January 1, 2025, it is 2026 that marks the transition to an operational phase.

9. Reduced compliance obligations for imported goods and services

Businesses that apply the reverse-charge mechanism for VAT purposes in the UAE may benefit from reduced compliance obligations. 

10. Substance and CbC reporting focus

Tax authorities are expected to continue strengthening the enforcement of economic substance and Country-by-Country (CbC) reporting frameworks. In the UAE, these regimes are increasingly being used as risk-assessment tools, providing tax authorities with a comprehensive view of multinational groups’ global footprints and enabling them to assess whether profits are aligned with real economic activity. 

Contributed by Thomas Vanhee and Hend Rashwan, Aurifer

Disability on screen

Empire — neuromuscular disease myasthenia gravis; bipolar disorder; post-traumatic stress disorder (PTSD)

Rosewood and Transparent — heart issues

24: Legacy — PTSD;

Superstore and NCIS: New Orleans — wheelchair-bound

Taken and This Is Us — cancer

Trial & Error — cognitive disorder prosopagnosia (facial blindness and dyslexia)

Grey’s Anatomy — prosthetic leg

Scorpion — obsessive compulsive disorder and anxiety

Switched at Birth — deafness

One Mississippi, Wentworth and Transparent — double mastectomy

Dragons — double amputee

AI traffic lights to ease congestion at seven points to Sheikh Zayed bin Sultan Street

The seven points are:

Shakhbout bin Sultan Street

Dhafeer Street

Hadbat Al Ghubainah Street (outbound)

Salama bint Butti Street

Al Dhafra Street

Rabdan Street

Umm Yifina Street exit (inbound)

French business

France has organised a delegation of leading businesses to travel to Syria. The group was led by French shipping giant CMA CGM, which struck a 30-year contract in May with the Syrian government to develop and run Latakia port. Also present were water and waste management company Suez, defence multinational Thales, and Ellipse Group, which is currently looking into rehabilitating Syrian hospitals.

Winners

Ballon d’Or (Men’s)
Ousmane Dembélé (Paris Saint-Germain / France)

Ballon d’Or Féminin (Women’s)
Aitana Bonmatí (Barcelona / Spain)

Kopa Trophy (Best player under 21 – Men’s)
Lamine Yamal (Barcelona / Spain)

Best Young Women’s Player
Vicky López (Barcelona / Spain)

Yashin Trophy (Best Goalkeeper – Men’s)
Gianluigi Donnarumma (Paris Saint-Germain and Manchester City / Italy)

Best Women’s Goalkeeper
Hannah Hampton (England / Aston Villa and Chelsea)

Men’s Coach of the Year
Luis Enrique (Paris Saint-Germain)

Women’s Coach of the Year
Sarina Wiegman (England)